An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis

Ann Rheum Dis. 2014 Jun;73(6):1273-4. doi: 10.1136/annrheumdis-2013-204938. Epub 2014 Feb 12.
No abstract available

Keywords: Ankylosing Spondylitis; Magnetic Resonance Imaging; Treatment.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone Density Conservation Agents / therapeutic use*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Imidazoles / therapeutic use*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Osteitis / drug therapy*
  • Spondylitis, Ankylosing / drug therapy*
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid